Persistent deactivation of TrkB receptor under stress conditions not only hampers the axonal regeneration and other neuroprotective effects of BDNF and NT4 [161] but also at least in part explains why the protective effects of BDNF therapy on RGC survival following experimental glaucoma conditions have only transient outcomes. This evidence concerns the gene BDNF and glaucoma.